Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Research tells us that eating enough protein and staying physically active can be helpful in reducing the amount of non-fat ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

More and more people are taking weight loss injectables like Wegovy — but not everyone prescribed these drugs should have ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

It's a case study of how savvy marketing can propel a company to the forefront of its industry. Weight Watchers is clearly the dominant company among weight-loss centers and programs, banking north of ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds.

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity. The dramatic ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.